Startseite
Märkte
Charts & Ideen
Algo
Nachrichten
Store
Broker
Herunterladen
Wirtschaftskalender
Handelssignale
WebTerminal
Geben Sie
/
ein, um zu suchen: @user, $symbol
Suche
Einloggen
Eröffnen Sie ein Konto
Deutsch
English
Русский
中文
Español
Português
日本語
한국어
Français
Italiano
Türkçe
SPRO
#3194
Spero Therapeutics, Inc. Common Stock
2.1
7
-0.46%
Sektor:
Basis:
Gewinnwährung:
Tagesspanne
Jahresspanne
Tagesänderung
-0.46%
Monatliche Änderung
-8.05%
6 month change
+10.15%
Jahresänderung
+178.21%
Vorheriger Schlusskurs
2.1
8
Open
2.1
7
Bid
Ask
Low
2.1
7
High
2.1
7
Volumen
8
Märkte
Aktien
Gesundheitswesen
SPRO
Open full chart
Financials
Overview
Finanzbericht
Statistics
Dividends
Quarterly
Annual
Value
2020
2021
2022
2023
2024
TTM
Key stats
Total common shares outstanding
29.5 M
32.76 M
52.57 M
53.87 M
55.9 M
—
Valuation ratios
Enterprise value
486.88 M
411.84 M
-17.63 M
5.55 M
4.69 M
185.36 M
Price to earnings ratio
—
—
-1.41
3.53
-0.81
-6.71
Price to sales ratio
—
—
1.22
0.78
1.16
7.85
Price to cash flow ratio
—
—
-8.46
-2.44
-2.37
6.05
Price to book ratio
—
—
0.86
0.75
1.21
3.01
Enterprise value to EBITDA ratio
—
—
—
—
—
—
Profitability ratios
Return on assets %
0.51
0.52
0.37
0.13
0.62
0.53
Return on equity %
0.59
1.02
0.61
0.21
1.49
1.19
Return on invested capital %
1 225.35
1 563.16
698.97
122.86
412.12
—
Gross margin %
100
100
100
100
100
400
Operating margin %
847.94
481.87
78.86
20.7
152.91
557.88
EBITDA margin %
—
—
—
—
—
—
Net margin %
839.23
491.89
86.74
21.98
142.91
522.53
Liquidity ratios
Quick ratio
—
—
—
—
—
—
Current ratio
9.7
8.46
5.25
3.53
2.19
12.56
Inventory turnover
—
—
—
—
—
—
Asset turnover
0.07
0.11
0.36
0.68
0.33
0.48
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
Long term debt to total assets ratio
0
0
0
0
0
—
Long term debt to total equity ratio
0
0
0
0
0
—
Per share metrics
Operating cash flow per share
—
—
0.21
0.62
0.43
-1.13
EBIT per share
—
—
—
—
—
—
EBITDA per share
—
—
—
—
—
—
Total debt per share
—
—
—
—
—
—
Cash per share
—
—
2.9
1.44
0.98
3.28
Net current asset value per share
—
—
3.02
2.48
1.99
5.32
Tangible book value per share
—
—
2.02
2.02
0.85
2.52
Working capital per share
—
—
2.45
1.77
1.08
3.38
Book value per share
—
—
2.02
2.02
0.85
2.52
Nachrichten
Spero Therapeutics: Tebipenem’s FDA Path Supports A Speculative Buy (NASDAQ:SPRO)
Spero Therapeutics: COO veräußert Aktien im Wert von 44.000 US-Dollar
Keutzer, Spero Therapeutics COO, sells $44k in shares
Insider-Verkauf bei Spero Therapeutics: CEO veräußert Aktien im Wert von 207.000 US-Dollar
Spero Therapeutics CEO sells $207k in stock
GSK's Q4 Earnings & Sales Beat Estimates, Stock Up on '26 Outlook
Spero Therapeutics announces board resignation and SEC investigation closure
GSK files NDA resubmission for Spero’s tebipenem HBr antibiotic
Spero Therapeutics: EPS übertrifft Schätzungen um 0,26 $ - Umsatz schlechter als erwartet
Spero Therapeutics earnings beat by $0.26, revenue fell short of estimates
Spero Therapeutics: CEO verkauft Aktien nach starkem Kursanstieg
Spero therapeutics CEO Rajavelu sells $95k in stock